Clinical Trials Browser

Phase 1 × Advanced Cancers × Vorinostat × Clear all

NCT02042989 2022-07-11

MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies

Phase 1 Completed

Advanced Cancers

NCT01608139 2012-10-19

Study of Curcumin, Vorinostat, and Sorafenib

Phase 1 Withdrawn

Advanced Cancers